Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Users Online: 236
About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Advertise Login 

    Article Cited by others


Oral nystatin versus intravenous fluconazole as neonatal antifungal prophylaxis: Non-inferiority trial

Mersal Ali, Alzahrani Ibrahim, Azzouz Mahasen, Alsubhi Adel, Alsawaigh Heba, Albshri Nouf, Bajammal Manal, Avand Ghazal, Almahbosh Abdulmajid

Year : 2013| Volume: 2| Issue : 2 | Page no: 88-92

   This article has been cited by
1 Unbiasing costs? An appraisal of economic assessment alongside randomized trials in neonatology
Susanne Hay,Meredith Mowitz,Dmitry Dukhovny,Christine Viner,Jonathan Levin,Brian King,John A.F. Zupancic
Seminars in Perinatology. 2021; : 151391
[Pubmed]  [Google Scholar] [DOI]
2 Oral nystatin prophylaxis to prevent systemic fungal infection in very low birth weight preterm infants: a randomized controlled trial
Lily Rundjan,Retno Wahyuningsih,Chrissela Anindita Oeswadi,Miske Marsogi,Ayu Purnamasari
BMC Pediatrics. 2020; 20(1)
[Pubmed]  [Google Scholar] [DOI]
3 Comparison of nystatin and fluconazole effects in the healing of oral candidiasis in immunocompromised individuals: A systematic review
Miloš Stepovic,Dalibor Stajic,Marija Sekulic,Milena Maricic,Merima Goran,Zlata Rajkovic,Nela Ðonovic
Medicinski casopis. 2018; 52(4): 145
[Pubmed]  [Google Scholar] [DOI]
4 Fluconazole Doses Used for Prophylaxis of Invasive Fungal Infection in Neonatal Intensive Care Units: A Network Meta-Analysis
Letícia Paula Leonart,Fernanda Stumpf Tonin,Vinicius Lins Ferreira,Suelem Tavares da Silva Penteado,Fábio de Araújo Motta,Roberto Pontarolo
The Journal of Pediatrics. 2017;
[Pubmed]  [Google Scholar] [DOI]
5 Management of candidemia in patients withClostridium difficileinfection
Marco Falcone,Mario Venditti,Maurizio Sanguinetti,Brunella Posteraro
Expert Review of Anti-infective Therapy. 2016; 14(7): 679
[Pubmed]  [Google Scholar] [DOI]
6 Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants
Nicola Austin,Jemma Cleminson,Brian A Darlow,William McGuire
Cochrane Database of Systematic Reviews. 2015;
[Pubmed]  [Google Scholar] [DOI]
7 Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants
Jemma Cleminson,Nicola Austin,William McGuire
Cochrane Database of Systematic Reviews. 2015;
[Pubmed]  [Google Scholar] [DOI]
8 Probiotic supplementation for preventing invasive fungal infections in preterm neonates - a systematic review and meta-analysis
Sachin Agrawal,Shripada Rao,Sanjay Patole
Mycoses. 2015; 58(11): 642
[Pubmed]  [Google Scholar] [DOI]
9 Topical Nystatin for the Prevention of Catheter-Associated Candidiasis in ELBW Infants
Mary Beth Bodin,Guillermo Godoy,Joseph B. Philips
Advances in Neonatal Care. 2015; 15(3): 220
[Pubmed]  [Google Scholar] [DOI]
10 Current Epidemiology and Management of Invasive Candidiasis in Infants
Kanecia O. Zimmerman,P. Brian Smith
Current Fungal Infection Reports. 2014;
[Pubmed]  [Google Scholar] [DOI]
11 Stimulation of Erythrocyte Cell Membrane Scrambling by Nystatin
Abaid Malik,Rosi Bissinger,Kashif Jilani,Florian Lang
Basic & Clinical Pharmacology & Toxicology. 2014; : n/a
[Pubmed]  [Google Scholar] [DOI]


Read this article